Your browser doesn't support javascript.
loading
Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways.
Chen, Qinwei; Deng, Suqi; Deng, Manman; Shi, Yuanfei; Zhong, Mengya; Ding, Lihong; Jiang, Yuelong; Zhou, Yong; Carter, Bing Z; Xu, Bing.
Afiliación
  • Chen Q; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361102, People's Republic of China.
  • Deng S; Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, 361102, China.
  • Deng M; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
  • Shi Y; Institute of Hematology, School of Medicine, Jinan University, Guangzhou, 510632, China.
  • Zhong M; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361102, People's Republic of China.
  • Ding L; Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, 361102, China.
  • Jiang Y; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361102, People's Republic of China.
  • Zhou Y; Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, 361102, China.
  • Carter BZ; Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, 361102, People's Republic of China.
  • Xu B; Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, 361102, China.
Exp Hematol Oncol ; 11(1): 23, 2022 Apr 16.
Article en En | MEDLINE | ID: mdl-35429966

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Exp Hematol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Exp Hematol Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido